LivaNova plc (LIVN) Tops Q2 EPS by 15c, Revenues Beat; Updates FY20 EPS Mid-Point Guidance Below Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. AMD
2. BKNG
3. DOX
4. AMGN
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to LivaNova plc (LIVN) Tops Q2 EPS by 15c, Revenues Beat; Updates FY20 EPS Mid-Point Guidance Below Consensus

LivaNova Reports Second Quarter 2020 Results

July 29, 2020 5:00 AM EDT

LONDON--(BUSINESS WIRE)-- LivaNova PLC (NASDAQ: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter ended June 30, 2020.

For the second quarter of 2020, worldwide sales from continuing operations were $182.2 million, a decrease of 34.3 percent on a reported basis and a decline of 33.1 percent on a constant-currency1 basis, as compared to the same quarter of the previous year. On the basis of U.S. Generally Accepted Accounting Principles (GAAP), second quarter 2020 diluted loss per share from continuing operations was $1.81. Second quarter 2020 adjusted diluted loss per share from continuing operations was... More